ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

52
Analysis
Health CareTaiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
12 Aug 2024 06:40

Taiwan Top 50 ETF Rebalance Preview: One Change Right at the Cusp

There could be one change for the Taiwan Top 50 ETF in September. Review cutoff is two weeks away and there are some stocks that are close to the...

Logo
233 Views
Share
25 Jun 2024 22:32

Pharmaessentia Corp (6446 TT): Starts 2024 on Strong Note; Reports First Operating Profit in 1Q24

​Pharmaessentia reports strong 1Q24 results with increased revenue, decreased operating expenses, and first-time operating profit. Geography and...

Logo
229 Views
Share
07 Mar 2024 09:30

Pharmaessentia Corp (6446 TT): Readying for Next Growth Phase with Besremi’s Continued Traction

​Pharmaessentia reports 103% YoY revenue growth in first two months of 2024. The company is expected to turn profitable this year. China approval...

Logo
251 Views
Share
03 Nov 2024 07:30

APAC Healthcare Weekly (Nov 3)- Eisai, Takeda, Shionogi, Astellas Pharma, Celltrion, Wuxi AppTec

Large APAC healthcare companies are reporting mixed earnings. Demography will play a key role in ensuring how the overall domestic demand scenario...

Logo
451 Views
Share
07 Oct 2024 07:05

TWSE Foreign Holding Weekly (Oct 4th): Via Technologies, TSMC, United Microelectronics

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Via Technologies, TSMC, United Microelectronics,...

Logo
198 Views
Share
x